Podcast appearances and mentions of andrew mckenzie

Andrew McKenzie et Chris Simpson présentent La Belle France au Adelaide Fringe Festival le 23 février prochain. Ce sera une sélection des chansons traditionnelles françaises. Ils se produisent régulièrement dans les productions de l'Alliance Française d'Adelaide et du Panache Adelaide French Theatre.

Avec nous pour en parler Andrew McKenzie, membre de Panache Adelaide French Theatre.

Potato production in Northeastern North America can lead to stagnant yields and declining soil health. This is why practices such as cover cropping and the use of manure are important. However, these practices also lead to increased weed problems by adding seeds into the weed seedbank. A recent AAFC study explored how cover crops and manure affect weed populations in a potato crop rotation over three years.To speak more about the study, the process and insights gleaned are Judith Nyiraneza and Andrew McKenzie-Gopsill of AAFC. They discuss the background of the still-ongoing research project, insights into the various cover crop/manure combinations, and discuss why weed seeds in manure did not necessarily evolve into dense weed spread.

On the Heather du Plessis-Allan Drive Full Show Podcast for Tuesday, 2 July 2024, the Government has announced it's plan to help the struggling media industry. Broadcasting Minister Paul Goldsmith tells Heather why Facebook may boycott NZ media as a result and how he's trying to help Shortland Street. Wairoa mayor Craig Little is calling on Hawke's Bay Regional Council to apologise for its part in last week's devastating floods in the town. US law professor Randy Zelin speaks to Heather after the US Supreme Court ruled Donald Trump would have immunity on any official decisions he made as president. Plus, the Huddle debates whether Kainga Ora boss Andrew McKenzie should have been paid $365,000 to leave his job. Get the Heather du Plessis-Allan Drive Full Show Podcast every weekday evening on iHeartRadio, or wherever you get your podcasts. LISTEN ABOVESee omnystudio.com/listener for privacy information.

State housing provider and developer Kainga Ora is losing its chief executive and most of its board, as the government's plans for social housing remain unclear. The chief executive, Andrew McKenzie, has resigned - and will get 365-thousand dollar payout. And five of seven board members are also going. Chair of Kainga ora, Simon Moutter spoke to Ingrid Hipikiss.

Public housing agency Kainga Ora's woes seem set to continue with chief executive Andrew McKenzie stepping down over the government's overhaul. Prime Minister Christoper Luxon spoke to Ingrid Hipikiss.

State housing advocates believe more people will become homeless, living on the street and in garages, as a result of the government's neutering of Kainga Ora. Five board members are going, and the chief executive Andrew McKenzie has resigned. Child Poverty Action Group's housing spokesperson Alan Johnson spoke to Corin Dann.

A former community housing leader says those providers are ready to collaborate with the Government.   Kainga Ora chief executive Andrew McKenzie has resigned, saying the Government's changes aren't what he signed up for.   It comes after a scathing review of the organisation.   Former Monte Cecilia Housing Trust CEO Bernie Smith told Mike Hosking that the last Government stopped community housing providers buying houses from developers, but did it themselves.   He says time and time again first home owners were locked out of the market because Kainga Ora came along with a big chequebook.  LISTEN ABOVE See omnystudio.com/listener for privacy information.

The Prime Minister is clarifying a six-figure redundancy payment to the resigning Kainga Ora CEO.  Christopher Luxon says it was not a decision made by the Government.  The public housing agency's chief executive Andrew McKenzie says he didn't sign up for an overhaul of Kainga Ora.  He's in for a payment of $365 thousand.  Luxon told Newstalk ZB's Mike Hosking that those arrangements sit with the chair Simon Mouttar, but he calls it an under-performing organisation.   He says they're refreshing the board.  Luxon said that he doesn't know the details of the redundancy, and doesn't want to, what he wants to know is that the organisation is starting to get better. The Prime Minister has also pledged to address law and order during the Government's plan for the third quarter of this year, although he was often coy when asked about specific details of policies.   Luxon published his Government's plan for the third quarter on Monday. The plan covers the period from July to the end of September and included 40 “actions” across areas like the economy and climate change, but Luxon said law and order would be his priority.   “The Government I lead is one of action and we are already making meaningful changes that will keep Kiwis safe in their homes, workplaces and communities,” Luxon said. The plan pledges the Government to giving police “tough powers to go after gangs by restricting their ability to associate and banning gang patches in public” and the power to “get guns out of the hands of criminals”.  While plans for a Government's first 100 days in office have become fairly common features of New Zealand politics, Luxon decided his Government would adopt a 100 day plan-style approach to its entire term of Government by publishing a plan each quarter of what “actions” the Government intends to tick off over the next three months.  Speaking to Newstalk ZB's Mike Hosking Breakfast, Luxon compared his progress throughout his time as Prime Minister to the many “corporate turnarounds” he has accomplished in his career, although he acknowledged the difference between a business and a country.  ”I am just focused on the must-do stuff right now, that's what you to do when you are turning stuff around… we can plant those seeds now that we can benefit from down the road.  ”If we don't do that, we are heading down a very dark road.”  Other significant pledges include to publish New Zealand's second Emissions Reduction Plan (ERP), the first such plan published by this Government. ERPs are meant to set out how a Government meets its emissions budgets under the Zero Carbon Act.  LISTEN ABOVE See omnystudio.com/listener for privacy information.

Kāinga Ora's Chief Executive Andrew McKenzie will be stepping down at the end of October, with a $365,000 payout. A review has found the state housing provider needs significant savings to be financially viable. Kainga Ora Chair Simon Moutter says it's the right time. "Given the extent of change going on in this organisation with the changes through the Government's budget allocations to KO and the findings of the independent review...it was only right." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Kāinga Ora's Chief Executive Andrew McKenzie will be stepping down at the end of October, with a $365,000 payout. A review has found the state housing provider needs significant savings to be financially viable. Kainga Ora Chair Simon Moutter says it's the right time. "Given the extent of change going on in this organisation with the changes through the Government's budget allocations to KO and the findings of the independent review...it was only right." LISTEN ABOVESee omnystudio.com/listener for privacy information.

Undeserved Privilege - Andrew Mckenzie - The Chapel 10am 25th Feb 2024 by The Chapel

Get In The River - Andrew McKenzie - The Chapel 10am 14th Jan 2024 by The Chapel

Value - Ps. Andrew McKenzie - The Chapel 10am 26th Nov 2023 by The Chapel

Be A Goose Ps. Andrew McKenzie The Chapel 10am 17th Sep 2023 by The Chapel

Eph 3.1 12 Ps Andrew McKenzie The Chapel 8.30am 6th Aug 2023 by The Chapel

Housing is on everyone's mind these days, and the top issue in Toronto, Canada's largest city's upcoming Mayoral election. This week on the pod, we bring together four amazing experts and ask the question, “If you were the Mayor, what would your housing platform be?”. You don't want to miss it as John Fox, Ene Underwood, Diana Chan McNally and Andrew McKenzie join me for a thought-provoking and entertaining conversation.

Ephesians And Courage Ps Phoebe And Andrew McKenzie The Chapel 830am 28th May 2023 by The Chapel

Courage Ps. Andrew McKenzie The Chapel 10am 28th May 2023 by The Chapel

Andrew McKenzie, Trey Malone, and Aleks Schaefer discuss about research on public policy impacts on agricultural risks.

Andrew McKenzie de Panache Adelaide French Theatre parle du nouveau spectacle «8 Femmes » de Robert Thomas, rendu célèbre au cinéma par François Ozon. La pièce sera présentée du 25 au 27 mai au Star Theatres d'Adelaide .

Daniel Ch 3 4 5 Ps. Phoebe And Andrew McKenzie The Chapel 8.30am 16th Apr 2023 by The Chapel

Daniel 3 Designed For Worship Ps. Andrew McKenzie The Chapel 10am 16th Apr 2023 by The Chapel

Andrew McKenzie, John Anderson, and Jason Wheeler discuss the fundamentals of grain marketing, including the role of grain elevators in the grain supply chain. 

John Anderson, Andrew McKenzie, and Hunter Biram discuss crop insurance issues including current price guarantees on Arkansas row crops and rate adjustments on RMA-designated higher-risk areas.

Daniel 2 + Outsiders Inside Together Ps. Phoebe and Andrew McKenzie The Chapel 8.30am 26th Feb 2023 by The Chapel

Outsiders Inside Stronger Together Ps. Andrew McKenzie The Chapel 10am 26th Feb 2023 by The Chapel

Daniel Ps.Andrew McKenzie Rip Up The List Ps.Bron Bonnell The Chapel 8.30am 19th Feb by The Chapel

Acts 16 Ps.Bron Bonnell Acts 17 God Is Near Ps.Andrew McKenzie The Chapel 8.30am 29th Jan 2023 by The Chapel

The Plan Does Not Change Ps. Andrew McKenzie The Chapel 10am 22nd Jan 2023 by The Chapel

On est en ligne avec Andrew McKenzie de Panache French Theatre d'Adelaide pour parler du nouveau spectacle « Le Mensonge » de Florian Zeller. Les spectacles auront lieu du 10 au 12 novembre prochain. On fait le point aussi sur le prochain spectacle « 8 Femmes » de Robert Thomas, rendu célèbre au cinéma par François Ozon qui sera présenté en 2023.

Acts 3 Ps. Andrew McKenzie - Love In Action Mikey Barlow The Chapel 8.30am 18th Sep 2022 by The Chapel

Acts Ps. Bron Bonnell Hospitality Ps. Andrew McKenzie The Chapel 8.30am 21st Aug 2022 by The Chapel

About the Guest Precision Livestock Technologies CEO Andrew McKenzie co-founded the company in 2019 to bring new sources of data and analytics to the livestock industry.  Prior to PLT, he held executive positions in several software companies, worked in venture capital in New York City, and was lead engineer at a global industrial gas company.  […]

... Show MoreWe Have No Data…We Have No Automation | Andrew McKenzie

In 2011, Agriculture and Agri-Food Canada (AAFC) scientists were researching ways to control European corn borer populations. In an effort to target the pest at its source, they developed a piece of equipment dubbed the “https://www.potatoesincanada.com/aafc-research-finds-new-lease-on-life-as-weed-seed-crusher/ (potato vine crusher).” The equipment successfully reduced ECB populations in a field, but the pest's ability to fly between fields meant all farms in an area would have to employ the technology for there to be a beneficial effect overall. The crusher went unused for a decade until one AAFC research scientist considered another use for it. In this episode of Tuber Talk, AAFC weed scientist Andrew McKenzie-Gopsill discusses the history of the potato vine crusher, how he found out about it, and the trials he's running to determine the crusher's potential for weed seed management.  Never miss an episode by subscribing on https://podcasts.apple.com/ca/podcast/tuber-talk/id1499514906 (Apple Podcasts), https://open.spotify.com/show/0gO1c5GXrfvDGXrbhc0X8J?si=ApJN2MBtTuOCT85t_x0nXQ (Spotify), https://podcasts.google.com/?feed=aHR0cHM6Ly9mZWVkcy5jYXB0aXZhdGUuZm0vY2FuYWRhcy1wb3RhdG8tcG9kY2FzdC8 (Google Podcasts), https://www.stitcher.com/podcast/inputs-by-top-crop-manager/tuber-talk (Stitcher), https://tunein.com/podcasts/Business--Economics-Podcasts/Tuber-Talk-p1296152/ (TuneIn) or wherever you listen to podcasts. The music used in this episode is Vital Signs from Purple Planet Music. Sponsored by Syngenta.

Parable. Workers In The Vineyard. Ps Andrew McKenzie. Desire. Dan Urqhart.The Chapel 8.30am 17072022 by The Chapel

Authentic Christianity Ps. Andrew McKenzie. The Chapel 10am 10072022 by The Chapel

Confession Ps. Bron Bonnell And Ps Andrew McKenzie. The Chapel 8.30am 10072022 by The Chapel

This week, Ryan talks with Dr. Andrew McKenzie-Gopsill, Weed Scientist with AAFC Charlottetown about a range of weed-related topics, including herbicide rotation and efficacy, herbicide timing, and some of the interesting cultural and mechanical weed seed destruction research that Andrew is working on.

John 14_17 Ps. Andrew McKenzie and Ps Darren Bonnell The Chapel 8.30am 22052022 by The Chapel

Gospel Of John Wk Ps. Andrew McKenzie Ps Darren Bonnel The Chapel 10am 15052022 by The Chapel

John Anderson, Andrew McKenzie, and James Mitchell with the University of Arkansas System Division of Agriculture and Jada Thompson with the University of Tennessee discuss the farm- and market-level impacts of the ongoing outbreak of highly-pathogenic avian influenza (HPAI) in commercial poultry operations.The following materials and/or data sources were referenced in this Relevant Risk episode:USDA Animal and Plant Health Inspection Service (APHIS) Avian Influenza web page, https://www.aphis.usda.gov/aphis/ourfocus/animalhealth/animal-disease-information/avian/avian-influenza

John Anderson, Andrew McKenzie, and Scott Stiles – economists with the University of Arkansas System Division of Agriculture – discuss the current market situation for Arkansas' major commercial row crops.

On est en ligne avec Andrew McKenzie du Panache Adelaide French Theatre pour parler du prochain spectacle, Muse en Noir, qui rend hommage à Juliette Gréco. Les représentations auront lieu au Nexus Arts Centre le 12, 13 et 14 mai prochain.  https://www.facebook.com/panacheadelaidefrenchtheatre/

So Andrew and I read and then geeked out about this book that apparently the Vatican just released in 2015. It is about the war that ended Giants, and giants are very interesting! Who knows how much validity it has, but it is worth a look. Here is the book: https://www.amazon.com/Books-Og-Enoch... WEBSITE: https://www.nikkianajones.com/ TELEGRAM: https://t.me/nikkiana_jones ​​​​​​​​​​IG: nikkiana_jones TWITTER: @LivingExtraord1 PODCAST: https://anchor.fm/nikkianajones CONTACT: Nikkianajones@protonmail.com ODYSEE: https://odysee.com/@nikkianajones:1 BITCHUTE: https://www.bitchute.com/channel/uXvR... --- Send in a voice message: https://anchor.fm/nikkianajones/message Support this podcast: https://anchor.fm/nikkianajones/support

The state landlord says it's been warned against evicting its worst tenants, with other agencies claiming it will undo their good work. Kainga Ora appeared before the Social Services and Community Select Committee this morning, defending the agency's track record on dealing with its most disruptive tenants. Chief executive Andrew McKenzie listed half a dozen state agencies who've told Kainga Ora any hope of helping its worst tenants goes out the window if the state landlord makes them homeless. Our political reporter Anneke Smith has the story.

"Gen 37_40 Joseph" Andrew McKenzie 8.30am The Chapel by The Chapel

Welcome to Relevant Risk from the Fryar Price Risk Management Center of Excellence. In this inaugural episode, director of the Fryar Center John Anderson sat down with Andrew McKenzie, the associate director of the Center, to introduce the podcast and discuss the overall aims of the Fryar Risk Management Center of Excellence.

Featuring perspectives from Drs Marc Ladanyi, Andrew McKenzie and Helena Yu, including the following topics: Introduction: Role of Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC) (0:00) Case: A woman in her mid-40s with newly diagnosed Stage IIB adenocarcinoma of the lung and an EGFR L858R mutation — Helena Yu, MD (13:33) Case: A man in his late 70s with metastatic NSCLC and osimertinib resistance due to acquired RET fusion — Marc Ladanyi, MD (23:08) Case: A woman in her mid-60s with newly diagnosed adenocarcinoma of the lung and an EGFR exon 20 mutation — Dr Yu (27:28) Case: A man in his late 70s with Stage IV adenocarcinoma of the lung and a RET fusion — Andrew J McKenzie, PhD (36:49) Case: A man in his late 60s with metastatic mucinous adenocarcinoma of the lung and a HER2 mutation — Spencer Bachow, MD (46:01) Case: A woman in her mid-30s with newly diagnosed metastatic NSCLC and an ALK mutation — Nikesh Jasani, MD (51:57) Case: A man in his late 70s with NSCLC and a TRK fusion — Dr McKenzie (53:24) Case: A woman in her mid-60s with discordant BRAF mutation testing results — Syed Zafar, MD (55:41) CME information and select publications

Featuring perspectives from Drs Marc Ladanyi, Andrew McKenzie and Joel Neal, including the following topics: Introduction (0:00) Role of Genomic Profiling; New Developments in Non-Small Cell Lung Cancer (NSCLC) with an EGFR Mutation (0:49) Case: A woman in her early 60s with NSCLC and an EGFR exon 19 deletion — Andrew J McKenzie, PhD (30:40) Case: A man in his early 50s with metastatic lung adenocarcinoma and an EGFR exon 20 mutation — Atif Hussein, MD, MMM (35:04) Case: A man in his early 50s with RET positive NSCLC — Joel W Neal, MD, PhD (48:48) Case: A woman in her mid-60s with metastatic NSCLC and a HER2 exon 20 insertion — Dr Neal  CME information and select publications

There is growing frustration over unruly Kāinga Ora tenants in south Auckland's Papakura and other areas around the country. An internal policy at the state rental agency heavily discourages evicting problem tenants. It's designed to prevent people being cycled through emergency and transitional housing - at a greater cost to taxpayers. Neighbours are reporting noise, illegal parking, dumped rubbish and violence. Kerre McIvor spoke to Manurewa-Papakura Ward Councillor Daniel Newman, he says Kāinga Ora is too soft.   National's Housing Spokesperson Nicola Willis called in to Newstalk ZB, she is hot on the issue, asking questions of the Associate Housing and Public Housing Minister Poto Williams. Kāinga Ora Chief Executive Andrew McKenzie joined Kerre McIvor. LISTEN ABOVE  

Welcome adventurous listeners to the 19th episode of Anechoic Chamber. This is the second part of our two-part exposition of the work and thoughts of our guest Andrew McKenzie. Working since the 1970s, McKenzie is particularly known for his pioneering efforts to expand the vocabulary of recorded sound, which itself expanded into a mission to enhance all modalities of perception - this has been carried out with his flagship project The Hafler Trio as well as in collaboration with artists such as Clock DVA, The Anti Group, and Psychic TV. Though certainly not the only arrow in his McKenzie's quiver, his extensive performing and recording career has both informed, and been informed by, a host of other creative activities drawing upon knowledge from both techno-scientific and esoteric realms: working as a computer programmer before (as he reminds me) there were “pictures” on computer screens. Teaching Tibetan language and calligraphy (and some Sanskrit). Writing books, editing video, designing everything from graphics to instructional materials, and working as both a hypnotherapist and psychotherapist. One of his more recent and significant ventures, dubbed by him “complementary education,” fuses insights gleaned from all of these distinct experiences, and involves conducting 14-hour long sound workshops aimed at re-discovering the creative process in a world obsessed with nominalization (in other words, with the act of devaluing a process by conceptualizing it as a thing or object). After fruitful residencies in the Netherlands, Sweden, Iceland and elsewhere, McKenzie now resides in Estonia, from which he joined our host for the following conversation. This comes with the disclaimer that, despite capturing several hours worth of useful material for these next couple episodes, we still emerge with little more than a snapshot of a legitimately eclectic and evolving personality. Additional audio segues provided by Thomas Bey William Bailey intro music: Pierre Bastien, "Gypsy Rhythm" Artist link: linktr.ee/simply_superior Anechoic Chamber links Host: www.thomasbeywilliambailey.net Donate via Paypal: tbwb@protonmail.com

Welcome adventurous listeners to the 18th episode of Anechoic Chamber. This will be the first in a two-part exposition of the work and thoughts of our guest Andrew McKenzie. Working since the 1970s, McKenzie is particularly known for his pioneering efforts to expand the vocabulary of recorded sound, which itself expanded into a mission to enhance all modalities of perception - this has been carried out with his flagship project The Hafler Trio as well as in collaboration with artists such as Clock DVA, The Anti Group, and Psychic TV. Though certainly not the only arrow in his McKenzie's quiver, his extensive performing and recording career has both informed, and been informed by, a host of other creative activities drawing upon knowledge from both techno-scientific and esoteric realms: working as a computer programmer before (as he reminds me) there were “pictures” on computer screens. Teaching Tibetan language and calligraphy (and some Sanskrit). Writing books, editing video, designing everything from graphics to instructional materials, and working as both a hypnotherapist and psychotherapist. One of his more recent and significant ventures, dubbed by him “complementary education,” fuses insights gleaned from all of these distinct experiences, and involves conducting 14-hour long sound workshops aimed at re-discovering the creative process in a world obsessed with nominalization (in other words, with the act of devaluing a process by conceptualizing it as a thing or object). After fruitful residencies in the Netherlands, Sweden, Iceland and elsewhere, McKenzie now resides in Estonia, from which he joined our host for the following conversation. This comes with the disclaimer that, despite capturing several hours worth of useful material for these next couple episodes, we still emerge with little more than a snapshot of a legitimately eclectic and evolving personality. Additional audio segues provided by Thomas Bey William Bailey intro music: Pierre Bastien, "Caravan" and "Au Prado" Artist link: https://linktr.ee/simply_superior Anechoic Chamber links Host: http://www.thomasbeywilliambailey.net Donate via Paypal: tbwb@protonmail.com

Rubab wonders what would be the best course of action in their situation. Sagi asks about what if the brake is always stronger than the gas, will there be no sleep? Andrew sleeps in short spurts of time and has struggled for 17 years. Mckenzie feels like she will never sleep again. Elisabeth gets scared of sleeping because she believes something will happen to her. Daniel hits a speed bump after some gastro medications. Sean has started CBT-I and hopes that this along with removal of alcohol will lead to sleeping well. This content does not constitute medical advice, diagnosis, or treatment, and should never replace any advice given to you by your physician or other qualified healthcare providers.

REMINISCENCE by John McAulay REMINISCENCE is a work of fiction based on the generations of the McKenzie brothers who came to Australia during the gold rush days of the 1850’s. It is related from the situation in a nursing home of one of their descendants, ‘the old man’, Andrew McKenzie, and his relationship with the nurses who attend him. It spans 160 years of Australia’s history and the characters participate in many of the major historical and social events that occurred over that time. ‘The old man’ is a Western Queensland grazier, a genuine old bushie who espouses conservative values and tries to influence all about him to adopt them too. On the other hand, controversial social issues such as the Stolen Generation, Vietnam War and family relationships are handled with sensitivity. The trials and tribulations of successive generations of McKenzies are detailed, family connections explored, and romances developed. Above all, it is a love story, with a piquant ending that brings the story to a heartwarming close. About The Author I have spent most of my working life in the dairy industry, both as owner and operator of a commercial farm and industry politics and management, which has allowed me to travel extensively, mainly around Australia and worldwide. I enjoy reading, love history, have an active imagination, and nearly eighty years of experience to draw on. After self-publishing AUSSIE YARNS consisting of twenty short stories in 2011, I embarked on my first novel entitled REMINISCENCE. It combines the modern-day life and experiences of an older man with his forebears' historical experiences who arrived in Australia in the gold rush days in the 1850s. I have since finished another novella entitled CASSIE, another book called YARNS, ANECDOTES AND MEMOIRS, and most recently a book called F WORDS, a compilation of articles on 100 interesting words which start with the letter F. I have also written more than 200 poems, a few of which have appeared in print following competitions. Just for fun, I converted eight of the stories from AUSSIE YARNS into plays and, using audience members to play the parts, stage them at gatherings of day-trippers, nursing homes, etc. I also give talks to school groups, study centers, holiday camps, and tour groups on various topics, including the Kilcoy Yowie. All this while I continue to run a little cattle property, breeding and fattening Droughtmasters. https://www.authorjohnmcaulay.com/ https://www.amazon.com/Reminiscence-John-McAulay/dp/0646910353/ref=sr_1_1?dchild=1&keywords=Reminiscence+John+McAulay&qid=1611014844&s=digital-text&sr=1-1 http://www.bluefunkbroadcasting.com/root/twia/gsh2021a.mp3

Andrew McKenzie de Panache Adelaide French Theatre nous parle du nouveau spectacle “ Rire c’est guérir” au Star Theatre d’Adelaide le 3, 4 et 5 juin prochain.

In this episode of School's IN, Jen talks to Fairview music teacher and parent Maggie Olivo, and PE teacher Andrew McKenzie about what makes their school great.

Andrew McKenzie de Panache Adelaide French Theatre nous parle de ce spectacle de Yasmina Reza qui aura lieu le 5, 6 et 7 novembre prochain. https://www.facebook.com/panacheadelaidefrenchtheatre/

Proceedings from the third in a 3-part webinar series. Featuring perspectives from Drs Marcia S Brose, Andrew McKenzie and Milan Radovich, including on the following topics: Part 1: Molecular Tumor Board Introduction (00:00) Case: A woman in her late 70s with ER-positive, HER2-negative metastatic breast cancer (ESR, CHEK2 and RET mutations) — Sulfi Ibrahim, MD (6:09) Case: A woman in her mid-40s with metastatic thymoma (MTOR gain-of-function mutation) — Milan Radovich, PhD (13:29) Case: A patient with leiomyosarcoma (BRCA germline mutation) — Andrew McKenzie, PhD (15:05) Case: A patient with bone-only disease — Dr Ibrahim (16:44) Part 2: New Molecular Targets in Thyroid Cancer Case: A woman in her late 30s with RAI-refractory papillary thyroid cancer — Marcia S Brose, MD, PhD (21:25) Case: A man in his late 60s with papillary thyroid cancer — Dr Brose (29:25) Case: A woman in her late teens with locally advanced medullary thyroid cancer — Dr Brose (36:04) Case: A frail woman in her late 70s with metastatic papillary thyroid cancer (CAD) — Dr Ibrahim (39:46) Case: A man in his late 50s with metastatic thyroid cancer (RET M918T gain-of-function mutation) — Dr Radovich (43:40) Case: A man in his early 70s with metastatic medullary thyroid cancer (RET mutation) — Dr McKenzie (46:27) Part 3: Targeting the FGFR Signaling Pathway in Cholangiocarcinoma Case: A woman in her late 50s with metastatic cholangiocarcinoma (FGFR2-BICC1 fusion) — Dr Radovich (48:28) Part 4: New Options in the Management of GIST Harboring PDGFR Mutations Case: A patient with GIST (PDGFRA) — Dr McKenzie (52:57) Case: A woman in her early 60s with metastatic GIST (gain-of-function PDGFRA D842Y mutation) — Dr Radovich (54:23) Part 5: Molecular Tumor Board (Continued) Case: A man in his late 70s with metastatic pancreatic cancer (EGFR exon 19 deletion) — Justin Peter Favaro, MD, PhD (55:30) CME information and select publications

Proceedings from the second in a 3-part webinar series. Featuring perspectives from Drs Alexander E Drilon, Andrew McKenzie and Milan Radovich, including on the following topics: Part 1: Case Presentations Introduction (00:00) Case: A woman in her early 70s with metastatic adenocarcinoma of the lung (ERBB2, PALB2) — Milan Radovich, PhD (2:50) Case: A man in his mid-70s with metastatic adenocarcinoma of the lung (BRAF V600E) — Andrew McKenzie, PhD (8:55) Case: A woman in her mid-70s with metastatic NSCLC (EGFR exon 19 insertion) — Sulfi Ibrahim, MD (12:38) Case: A man in his mid-60s with recurrent SCCHN (TMB 215 mut/Mb) — Dr Radovich (16:52) Case: A man in his early 60s with metastatic adenocarcinoma of the lung (STK11, BRCA) — Dr Ibrahim (20:55) Case: A woman in her early 30s with metastatic adenocarcinoma of the lung (EML4-RET fusion) — Alexander E Drilon, MD (25:52) Part 2: Beyond EGFR, BRAF and ALK — Actionable Biomarkers in NSCLC Faculty Presentation — Dr Drilon (27:49) Part 3: Case Presentations Case: A woman in her mid-60s with metastatic adenocarcinoma of the lung (RET fusion) — Dr McKenzie (40:15) Case: A man in his late 50s with metastatic adenocarcinoma of the lung (RET fusion) — Dr Ibrahim (44:59) Case: A man in his late 60s with metastatic pancreatic cancer (ERC1/RET fusion) — Dr Radovich (48:02) Case: A woman in her mid-70s with metastatic adenocarcinoma of the lung (EPS15-NTRK1) — Dr Drilon (50:28) Case: A man in his early 80s with metastatic adenocarcinoma of the lung (MET exon 14) — Dr McKenzie (52:14) Case: A woman in her mid-80s with Stage IIIB NSCLC (MET exon 14 skipping mutation) — Dr Ibrahim (55:43) Case: A man in his early 70s with metastatic NSCLC (MET exon 14 splice site mutation) — Dr Radovich (58:41) CME information and select publications

Proceedings from the first in a 3-part webinar series. Featuring perspectives from Drs Andrew McKenzie, Bryan P Schneider and Milan Radovich, including the following topics: Part 1: Case Discussions Introduction (00:00) Case: A man in his mid-70s with prostate cancer (AKT1 E17k mutation) — Milan Radovich, PhD and Bryan P Schneider, MD (5:39) Case: A frail woman in her early 80s with endometrial cancer (AKT mutation) — Sulfi Ibrahim, MD (7:45) Case: A man in his late 50s with salivary gland head and neck squamous cell carcinoma (NTRK3-ETV6 fusion) — Andrew McKenzie, PhD (14:53) Case: A man in his early 80s with bladder cancer (tumor mutational burden 67 mut/Mb) — Drs Radovich and Schneider (17:15) Case: A man in his late 60s with muscle-invasive bladder cancer (PIK3CA mutation, RET amplification) — Dr Ibrahim (21:57) Case: A man in his early 60s with cholangiocarcinoma (FGFR2 rearrangement) — Dr McKenzie (25:35) Part 2: FDA-Approved and Guideline-Endorsed Platforms for Genomic Testing Advantages and limitations of available assays (29:33) Part 3: Case Discussions Case: A woman in her mid-60s with glioblastoma (FGFR3-TACC3 fusion) — Drs Radovich and Schneider (39:21) Case: A man in his early 80s with cancer of unknown primary (TMPRSS2-ERG fusion) — Dr Ibrahim (41:43) Case: A woman in her mid-60s with metastatic breast cancer (PIK3CA, ESR1 mutations) — Dr McKenzie (48:03) Case: A woman in her mid-60s with pancreatic cancer (KRAS G12C mutation) — Drs Radovich and Schneider (52:52) Case: A woman in her mid-60s with metastatic adenocarcinoma of the lung (KRAS G12C mutation) — Dr McKenzie (54:45) CME information and select publications

Reincarnation loop, about remembering.   The sea or swimming pool of 3D incarnation and where we are all on that journey.   The Galactic council has like some issue with our emotion. Will they let us hang with them?    The 5th dimension and what that might be manifested.    Heaven and perfection, let's break that concept down! Check out our youtube channel:https://www.youtube.com/channel/UC9qJWqnmPhDLnZNllSQ8uQA  Please subscribe and share and engage, we are real humans! Check the link to the book I referenced by Andrew McKenzie here!  https://www.lulu.com/en/us/shop/andrew-mckenzie/wester-island/ebook/product-g9n7eq.html Email us at livingextraordinarypodcast@gmail.com --- Send in a voice message: https://anchor.fm/nikkianajones/message Support this podcast: https://anchor.fm/nikkianajones/support

Genomic Assays in the “Real” Oncology World: Exploring the Role of Genomic Testing in Guiding Treatment for Patients with Advanced Breast, Colorectal and Prostate Cancers. A roundtable discussion featuring Emmanuel S Antonarakis, MD, Johanna C Bendell, MD, Ian E Krop, MD, PhD and Andrew McKenzie, PhD moderated by Neil Love, MD. Produced by Research To Practice.

Genomic Assays in the “Real” Oncology World: Exploring the Role of Genomic Testing in Guiding Treatment for Patients with Advanced Breast, Colorectal and Prostate Cancers. A roundtable discussion featuring Emmanuel S Antonarakis, MD, Johanna C Bendell, MD, Ian E Krop, MD, PhD and Andrew McKenzie, PhD moderated by Neil Love, MD. Produced by Research To Practice.

Genomic Assays in the “Real” Oncology World: Exploring the Role of Genomic Testing in Guiding Treatment for Patients with Advanced Breast, Colorectal and Prostate Cancers. A roundtable discussion featuring Emmanuel S Antonarakis, MD, Johanna C Bendell, MD, Ian E Krop, MD, PhD and Andrew McKenzie, PhD moderated by Neil Love, MD. Produced by Research To Practice.

Genomic Assays in the “Real” Oncology World: Exploring the Role of Genomic Testing in Guiding Treatment for Patients with Advanced Breast, Colorectal and Prostate Cancers. A roundtable discussion featuring Emmanuel S Antonarakis, MD, Johanna C Bendell, MD, Ian E Krop, MD, PhD and Andrew McKenzie, PhD moderated by Neil Love, MD. Produced by Research To Practice.

Genomic Assays in the “Real” Oncology World: Exploring the Role of Genomic Testing in Guiding Treatment for Patients with Advanced Breast, Colorectal and Prostate Cancers. A roundtable discussion featuring Emmanuel S Antonarakis, MD, Johanna C Bendell, MD, Ian E Krop, MD, PhD and Andrew McKenzie, PhD moderated by Neil Love, MD. Produced by Research To Practice.

Genomic Assays in the “Real” Oncology World — Part 1: Genomic Assays and Colorectal Cancer — Featuring a roundtable discussion with Drs Emmanuel S Antonarakis, Johanna Bendell, Ian E Krop and Andrew McKenzie. Multiplex Genomic Assays and Their Role in Therapeutic Decision-Making Case: A man in his mid-80s with metastatic castration-resistant prostate cancer (mCRPC) whose disease progressed through multiple therapies is found to have CD274 (PD-L1) amplification, microsatellite instability (MSI)-high status and mutations in ATM and EGFR Effect of CD274 amplification on response to immune checkpoint inhibitors; activity of PARP inhibitors in patients with ATM mutations Advantages and limitations of multiplex genomic testing Role of serial testing to identify variations in genomic mutations or aberrations over time; potential benefit of liquid next-generation sequencing (NGS) panels Use of multiplex genomic assays by community oncologists and implications for clinical practice Optimal timing of genetic testing for patients diagnosed with metastatic disease Presentation (Dr McKenzie): Overview of multiplex genomic assay methodology Rationale for the use of serial testing and liquid assays to identify variations in genomic mutations or aberrations over time Differentiating between germline and somatic mutations in cancer tissue Perspective on the use of tissue versus liquid biopsy for genetic testing Sensitivity of liquid biopsies in detecting tumor mutations Available data exploring the impact of NGS use on patient outcomes Selection of a multiplex genomic assay for detecting genetic alterations Implications of multiplex genomic assay results for therapeutic decision-making Comprehensive Genetic Profiling and Precision Medicine for Metastatic Colorectal Cancer (mCRC) Specific biomarkers and genetic alterations routinely evaluated in clinical practice Effects of up-front multiplex genomic assay testing on outcomes for patients with mCRC Response to immune checkpoint inhibitors in patients with MSI-high mCRC (1:09:3s Presentation (Dr Bendell): Biomarker assessment in mCRC; role of multiplex testing Actionable genetic alterations in mCRC; detection of BRAF and HER2 mutations and implications for practice Rationale and indications for the assessment of MSI and DNA mismatch repair (MMR) status; emerging role of tumor mutational burden Role of liquid versus tumor biopsies for detecting genetic alterations MSI/MMR and tumor mutational burden as predictors of benefit from immune checkpoint inhibitors Emerging role for the assessment of neoantigen load Case (Dr Bendell): A man in his mid-50s with mCRC, Lynch syndrome and MSI-high status achieves a partial response to pembrolizumab as second-line therapy Case (Dr Bendell): A woman in her early 60s with microsatellite stable mCRC and a BRAF V600E mutation receives the combination of cetuximab, encorafenib and binimetinib after disease progression on FOLFOXIRI/bevacizumab Case (Dr Bendell): A man in his early 40s with HER2-positive mCRC receives trastuzumab and pertuzumab on a clinical trial after disease progression on FOLFIRI/bevacizumab and attains a partial response Novel HER2-targeted therapies under evaluation for patients with mCRC and HER2 alterations Analysis of the gut microbiome and strategies to enhance the immune response to cancer   CME information and select publications

Genomic Assays in the “Real” Oncology World — Part 2: Genomic Assays in Prostate and Breast Cancer — Featuring a roundtable discussion with Drs Emmanuel S Antonarakis, Johanna Bendell, Ian E Krop and Andrew McKenzie. NGS for Metastatic Prostate Cancer (mPC) and the Potential Clinical Significance of Genomic Alterations Genetic alterations assessed in routine practice, including MSI status, BRCA mutations and AR-V7 variants; role of multiplex testing Presentation (Dr Antonarakis): Biomarker assessment in mPC; detection of DNA damage repair abnormalities and prediction of benefit with PARP and PD-1 inhibitors Landscape of DNA damage repair mutations in newly diagnosed and metastatic prostate cancer Rationale for the use of PARP inhibitors for prostate cancer with BRCA or ATM mutations Genetic testing of primary and metastatic tumors for alterations in the DNA repair and androgen receptor (AR) signaling pathways Clinical significance and genetic detection of AR splice variants Results of the CARD trial: Cabazitaxel versus enzalutamide or abiraterone for patients with mCRPC previously treated with docetaxel who experience rapid disease progression on an AR-targeted agent Efficacy of olaparib for mCRPC Available data with rucaparib, niraparib and talazoparib for mCRPC Role of radium-223 dichloride for patients with mPC; novel combination approaches with radium-223 under investigation Sensitivity of BRCA1, BRCA2 and ATM mutations to PARP inhibitors Activity of PARP inhibitors in patients with breast, ovarian, prostate and pancreatic cancers with BRCA mutations Homologous recombination deficiency and response to PARP inhibitors Case (Dr Antonarakis): A man in his mid-40s with mCRPC and a BRCA2 mutation attains a complete response to olaparib Case (Dr Antonarakis): A man in his mid-60s diagnosed with de novo mPC and MSI-high status, high tumor mutation burden and an MSH2 mutation experiences an excellent response to pembrolizumab after multiple lines of therapy Association of ductal and intraductal prostate cancer with a high prevalence of DNA damage repair gene mutations Predictors of benefit with immune checkpoint inhibitors Multigene Testing and Detection of Genomic Alterations in Metastatic Breast Cancer (mBC) Role of MSI testing and multiplex genomic assays in mBC Assessment of PIK3CA and BRCA mutations and assays for ESR1 Presentation (Dr Krop): Biomarker assessment in mBC — ER-positive and triple-negative disease PTEN loss and implications for therapeutic decision-making for mBC ESR1 mutations and resistance to hormone therapy Efficacy of PARP inhibitors in patients with BRCA mutations HER2 expression in HER2 nonamplified cancers; activity of trastuzumab deruxtecan in HER2-low breast cancer PD-L1 and other biomarkers predictive of benefit from immunotherapy in triple-negative breast cancer (TNBC) Case (Dr Krop): A woman in her late 50s with de novo TNBC receives atezolizumab/nab paclitaxel as first-line therapy Case (Dr Krop): A woman in her early 60s with ER-positive, HER2-negative mBC and a germline BRCA2 mutation whose disease progresses through multiple therapies attains a partial response to olaparib The Sarah Cannon Experience with Molecular Tumor Boards The use of molecular tumor boards to review molecular profiling data and facilitate therapeutic decision-making CME information and select publications

Andrew McKenzie de Panache Adelaide French Theatre nous parle de la mise en scène des Fourberies de Scapin de Molière au Star Theatres. Carole Mallett dirigera la pièce. Les représentations auront lieu le 31 octobre, le 1er novembre et le 2 novembre. - Andrew McKenzie de Panache Adelaide French Theatre nous parle de la mise en scène des Fourberies de Scapin de Molière au Star Theatres. Carole Mallett dirigera la pièce. Les représentations auront lieu le 31 octobre, le 1er novembre et le 2 novembre.

Andrew McKenzie, Josiah Everett, and Jared Holman discuss the AU dating scene from a guy's perspective. Part 1 of 2 episodes that explore the current dating climate at AU. 

Agnes kicks off her podcast by answering two questions -- first, an interpersonal one from a wife who needs to skip a couple days of harvest, then, a marketing question: should farmers be using futures and options? Thanks to guest expert Dr. Andrew McKenzie and thanks for voice work by Mike Pearson and Delaney Howell from Ag News Daily!

In part 2 of our podcast, International Stunt Co-ordinator and Director Andrew McKenzie shares his business tips, and work advice with us! Creativity and artistic expression are found in the most unexpected places. Watch the vlog on YouTube.

How did an ex-ballet dancer with a 3rd-degree black belt in kick-boxing land up being a top director in Egypt? Can a career in stunt performance be creative? International Stunt Co-ordinator and Director Andrew McKenzie blows us away! Watch the vlog on YouTube.

An Intimate Conversation with Andrew McKenzie of The Hafler Trio (h3o) by Lainie Sevante' Wulkan

Jenny Ruth investigates high flying ceo Andrew McKenzie. Read more ($): https://www.nbr.co.nz/article/shoeshine-messes-emerge-after-high-flyer-takes-wing-jr-p-204258

On this episode of The Astral Hustle, I'm joined for a conversation about all things esoteric by Andrew McKenzie, a Scottish born hypnotist, psychotherapist, teacher, lecturer and artist. In his conceptual art as The Hafler Trio, Andrew has collaborated with artists such as Jonsi Birgisson (Sigur Ros), Michael Gira (Swans), Blixa Bargeld (Einstürzende Neubauten), Current 93, Nurse With Wound, Genesis P-Orridge, Autechre, Jóhann Jóhannsson and many others.  Check out Andrew at http://simplysuperior.org A few of his lectures:  https://vimeo.com/131277740https://vimeo.com/130013319 https://vimeo.com/131396552 The intro/outro music is Huit Octobre 1971 by Cortex - -  cory-allen.com/theastralhustle@_coryallen

A live show but there are technical problems so for the first 20 minutes there was a mixture of different music plus interference (edited out). As that gets sorted  Dave makes occasional announcements until Bob arrives to start his show. Bob introduces listenerss ideas for feeding "Tass" the Thameside cat. There's a demo tape from One Track Mind playing "Your Mother Doesn't Love You". At 8:00 Sarah has a 30 minute show absolutely packed with dedications. She also has Mark interviewing Dolly Mixture who played the Greyhound in Fulham. Lola Payola and The Schoolgirl Song gets played (again).Alex who plays highlights from the Circle Line Picnic where about 100 listeners took over a whole carriage. Dave has a civil service memo about not having keys attached to your belt as it's safety risk. Then as if the technical problems at the start weren't enough fifteen minutes into Dave's show begins the broadcast stops. Thameside Radio was raided by the DTI. More Thameside Radio 90.2 listeners getting mentions: Rob Leighton, Angus Dee, Mick Merry, Dolly Mixture, Ian Hobbs, Jim O'Reily of The Runes, John Hensley, Dave Booth, Adrian of One Track Radio, Andrew McKenzie, Ann Bednall from Southampton University